Amgen Inc vs Eli Lilly & Co.
AMGN vs LLY — side-by-side comparison from reported financials. AMGN leads 3, LLY leads 8 of 11 comparable metrics.
Amgen Inc
AMGN · Healthcare
$415.01+1.86%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | AMGN | LLY |
|---|---|---|
| Price | $415.01 | $1 177.20 |
| Market cap | $224B | $1.05T |
| Revenue (TTM) | $38.1B | $79.7B |
| Revenue growth | +11.8% | +31.7% |
| Net margin | 23.0% | 33.5% |
| Free cash flow | $10.2B | $18.2B |
| Net cash (debt) | ($40.9B) | ($35.2B) |
| 1-year price return | +40.5% | +37.6% |
| P/E | 25.7 | 41.6 |
| P/E vs own history (cheap-side %) | 35% | 88% |
| Dividend yield | 2.32% | 0.52% |
| Return on equity | 89% | 93% |
| Altman Z-score | 1.81 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 31,500 | 50,000 |
Full résumé-style profiles: AMGN CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.